AN2 Therapeutics Q3 EPS $(0.17) Beats $(0.20) Estimate
Benzinga Newsdesk 10 hours ago
NewsEarningsEarnings Beats
AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.20) by 15 percent. This is a 45.16 percent increase over losses of $(0.31) per share from
AN2 Therapeutics (NASDAQ:ANTX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.20) by 15 percent. This is a 45.16 percent increase over losses of $(0.31) per share from the same period last year.